Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
Standigm names Carl Foster chief business officer to expand strategic partnerships for AI drug discovery 2022-08-18 20:30
WeTrade Group Inc. Ready to kick-off a Strategic Partnership with Zhixun Bio through WeTrade's SaaS platform and its the Internet of Things (IoT) 2022-08-18 20:23
Zylox-Tonbridge maintains strong revenue and gross profit growth, including gross margin improvement driven by its platform-based strategy in 1H22 2022-08-18 14:57
WuXi Biologics Reports Strong 2022 Interim Results 2022-08-17 21:32
Novavax Nuvaxovid™ COVID-19 Vaccine Granted Expanded Provisional Approval in New Zealand as a First and Second Booster for Adults 2022-08-17 20:00
WuXi STA Breaks Ground for New Pharmaceutical Manufacturing Facility in Middletown, Delaware 2022-08-17 01:47
J INTS BIO, Oral presentation of Preclinical results of its Novel Oral 4th Generation EGFR TKI 'JIN-A02' at the 2022 World Conference on Lung Cancer in Vienna, Austria (IASLC 2022 WCLC) 2022-08-16 13:35
Bridge Biotherapeutics Receives FDA Authorization to Proceed with Phase 2 Study of BBT-877 2022-08-16 08:17
JIN-A02, A Novel 4th Generation EGFR TKI selected for the European Thoracic Oncology Platform - A First for Korean Pharma. 2022-08-12 10:13
WuXi ATU Announces Licensing Agreement with Janssen for TESSA™ Technology 2022-08-12 09:09
Panacell Biotech to conduct toxicity tests for NK cells, exosomes, and brown adipose-derived stem cells to treat patients with long COVID 2022-08-10 22:00
WeTrade Group Entered Into A Strategic Partnership With Jiqing, Acquiring Monkeypox Test Kits Exclusive Sales Channel 2022-08-10 20:36
Bridge Biotherapeutics Presents Promising Interim Clinical Study Results from Phase 1 Study of BBT-176 at WCLC 2022 2022-08-10 11:43
iNtRON developed New CRISPR/Cas technology specific for Bacteriophage as PHAGERUS® Platform 2022-08-10 09:00
Kintor Pharma Announces Completion of Subject Enrollment and Dosing in Phase I Clinical Trial of AR-PROTAC(GT20029) in China 2022-08-09 17:00
Inmagene and HUTCHMED Announce First Participants in Global Phase I Trial of IMG-004 2022-08-09 12:00
BGI Ranks No. 1 among APAC and China Life Science Corporations for Seven Consecutive Years: 2022 Nature Index Annual Tables Revealed 2022-08-08 22:00
ImmVira's Brand New oHSV Product MVR-C5252 Targeting Malignant Glioma Obtained FDA's Orphan Drug Designation 2022-08-08 08:30
Epigenic Therapeutics Raises $20 Million in Series Angel and Pre-A Funding to Advance Next Generation Gene Editing Therapy 2022-08-07 07:00
United BioPharma's Study Reveals New Class of Monoclonal Antibody for Effective Relief of Urticaria Symptoms 2022-08-05 20:45
1 71 72 73 74 75 220